Deletion of the GI-2 Integrase and the WbkA Flanking Transposase Improves the Stability of Brucella Melitensis Rev 1 Vaccine
Overview
Authors
Affiliations
Brucella melitensis Rev 1 is the best vaccine available for the prophylaxis of small ruminant brucellosis and, indirectly, for reducing human brucellosis. However, Rev 1 shows anomalously high rates of spontaneous dissociation from smooth (S) to rough (R) bacteria, the latter being inefficacious as vaccines. This S-R instability results from the loss of the O-polysaccharide. To overcome this problem, we investigated whether some recently described mechanisms promoting mutations in O-polysaccharide genes were involved in Rev 1 S-R dissociation. We found that a proportion of Rev 1 R mutants result from genome rearrangements affecting the wbo O-polysaccharide loci of genomic island GI-2 and the wbkA O-polysaccharide glycosyltransferase gene of the wbk region. Accordingly, we mutated the GI-2 int gene and the wbk IS transposase involved in those arrangements, and found that these Rev 1 mutants maintained the S phenotype and showed lower dissociation levels. Combining these two mutations resulted in a strain (Rev 2) displaying a 95% decrease in dissociation with respect to parental Rev 1 under conditions promoting dissociation. Rev 2 did not differ from Rev 1 in the characteristics used in Rev 1 typing (growth rate, colonial size, reactivity with O-polysaccharide antibodies, phage, dye and antibiotic susceptibility). Moreover, Rev 2 and Rev 1 showed similar attenuation and afforded similar protection in the mouse model of brucellosis vaccines. We conclude that mutations targeting genes and DNA sequences involved in spontaneous O-polysaccharide loss enhance the stability of a critical vaccine phenotype and complement the empirical stabilization precautions taken during S Brucella vaccine production.
Wzm/Wzt System: Changes in the Bacterial Envelope Lead to Improved Rev1Δ Vaccine Properties.
Mena-Bueno S, Poveda-Urkixo I, Irazoki O, Palacios L, Cava F, Zabalza-Barangua A Front Microbiol. 2022; 13:908495.
PMID: 35875565 PMC: 9306315. DOI: 10.3389/fmicb.2022.908495.
Meta-Analysis and Advancement of Brucellosis Vaccinology.
Carvalho T, Haddad J, Paixao T, Santos R PLoS One. 2016; 11(11):e0166582.
PMID: 27846274 PMC: 5112997. DOI: 10.1371/journal.pone.0166582.
Smooth to Rough Dissociation in Brucella: The Missing Link to Virulence.
Mancilla M Front Cell Infect Microbiol. 2016; 5:98.
PMID: 26779449 PMC: 4700419. DOI: 10.3389/fcimb.2015.00098.
Innocuity and immune response to Brucella melitensis Rev.1 vaccine in camels (Camelus dromedarius).
Benkirane A, El Idrissi A, Doumbia A, De Balogh K Open Vet J. 2015; 4(2):96-102.
PMID: 26623347 PMC: 4629599.
Brucella dissociation is essential for macrophage egress and bacterial dissemination.
Pei J, Kahl-McDonagh M, Ficht T Front Cell Infect Microbiol. 2014; 4:23.
PMID: 24634889 PMC: 3942807. DOI: 10.3389/fcimb.2014.00023.